CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K Reporting owner sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +40,243 | 40,243 | ||
| 2024-06-14 | MOTT DAVID M Director | Grant or award | +17,322 | 1,209,597 | ||
| 2024-06-14 | MOTT DAVID M Director | Grant or award · Stock Option (Right to Buy) | +40,243 | 40,243 | ||
| 2024-06-13 | RAAB MICHAEL President & CEO | Exercise or conversion 10b5-1 | +35,000 | $0.99 | $35K | 1,305,273 |
| 2024-06-13 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −35,000 | $6.65 | $233K | 1,270,273 |
| 2024-06-13 | RAAB MICHAEL President & CEO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −35,000 | 665,000 | ||
| 2024-06-05 | Williams Laura A Chief Medical Officer | Exercise or conversion | +100,000 | $2.75 | $275K | 467,152 |
| 2024-06-05 | Williams Laura A Chief Medical Officer | Sale | −45,000 | $7.12 | $321K | 422,152 |
| 2024-06-05 | Williams Laura A Chief Medical Officer | Sale | −100,000 | $7.13 | $713K | 322,152 |
| 2024-06-05 | Williams Laura A Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 251,000 | ||
| 2024-06-03 | Rosenbaum David P. Chief Development Officer | Sale | −17,872 | $7.00 | $125K | 158,502 |
| 2024-05-29 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −7,500 | $6.72 | $50K | 1,270,273 |
| 2024-05-21 | Williams Laura A Chief Medical Officer | Sale | −4,794 | $7.81 | $37K | 367,152 |
| 2024-05-21 | Rosenbaum David P. Chief Development Officer | Sale | −4,855 | $7.81 | $38K | 376,479 |
| 2024-05-21 | Rosenbaum David P. Chief Development Officer | Sale | −2,198 | $7.81 | $17K | 176,374 |
| 2024-05-21 | Rodriguez Susan Chief Commercial Officer | Sale | −6,703 | $7.81 | $52K | 449,092 |
| 2024-05-21 | Renz Justin A Chief Financial Officer | Sale | −5,167 | $7.81 | $40K | 300,546 |
| 2024-05-21 | RAAB MICHAEL President & CEO | Sale | −31,484 | $7.81 | $246K | 1,277,773 |
| 2024-05-21 | GRAMMER ELIZABETH A | Sale | −6,927 | $7.81 | $54K | 199,469 |
| 2024-05-21 | Felsch Robert Ora | Sale | −3,485 | $7.81 | $27K | 95,127 |
Page 14 of 18 · 360 trades